Cholesterol contributes to the organization of tetraspanin-enriched microdomains and to CD81-dependent infection by malaria sporozoites

Journal of Cell Science

Volumn 119, Issue 10, 2006, Pages 1992-2002

  Silvie, Olivier ^a,b   Charrin, Stéphanie ^a,c,d,h   Billard, Martine ^a,c,d   Franetich, Jean Frano̧is ^a,b   Clark, Krista L ^e,i   van Gemert, Geert Jan ^f   Sauerwein, Robert W ^f   Dautry, François ^c,d,g   Boucheix, Claude ^a,c,d   Mazier, Dominique ^a,b   Rubinstein, Eric ^a,c,d  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d INSTITUT ANDRÉ LWOFF   (France)

^e KANSAS STATE UNIVERSITY   (United States)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g CNRS   (France)

^h INSTITUT PASTEUR   (France)

ⁱ CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Cholesterol; Malaria; Microdomains; Plasmodium; Tetraspanins

Indexed keywords

CD81 ANTIGEN; CHOLESTEROL; MONOCLONAL ANTIBODY; SMALL INTERFERING RNA; TETRASPANIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPID ANALYSIS; MALARIA; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; SPOROZOITE;

ANIMALS; ANTIGENS, CD; CELL LINE, TUMOR; CELL MEMBRANE; CHOLESTEROL; HELA CELLS; HUMANS; MALARIA; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; PLASMODIUM; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; SPOROZOITES;

PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII;

EID: 33745195489     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.02911     Document Type: Article

References (66)

1. Bartosch, B., Vitelli, A., Granier, C., Goujon, C., Dubuisson, J., Pascale, S., Scarselli, E., Cortese, R., Nicosia, A. and Cosset, F. L. (2003). Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J. Biol. Chem. 278, 41624-41630.
2. Berditchevski, F., Zutter, M. M. and Hemler, M. E. (1996). Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). Mol. Biol. Cell 7, 193-207.
3. Berditchevski, F., Odintsova, E., Sawada, S. and Gilbert, E. (2002). Expression of the palmitoylation-deficient CD151 weakens the association of alpha 3 beta 1 integrin with the tetraspanin-enriched microdomains and affects integrin-dependent signaling. J. Biol. Chem. 277, 36991-37000.
4. Boucheix, C. and Rubinstein, E. (2001). Tetraspanins. Cell Mol. Life Sci. 58, 1189-1205.
5. Charrin, S., Le Naour, F., Oualid, M., Billard, M., Faure, G., Hanash, S. M., Boucheix, C. and Rubinstein, E. (2001). The major CD9 and CD81 molecular partner. Identification and characterization of the complexes. J. Biol. Chem. 276, 14329-14337.
6. Charrin, S., Manie, S., Oualid, M., Billard, M., Boucheix, C. and Rubinstein, E. (2002). Differential stability of tetraspanin/tetraspanin interactions: role of palmitoylation. FEBS Lett. 516, 139-144.
7. Charrin, S., Le Naour, F., Labas, V., Billard, M., Le Caer, J. P., Emile, J. F., Petit, M. A., Boucheix, C. and Rubinstein, E. (2003a). EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells. Biochem. J. 373, 409-421.
8. Charrin, S., Manie, S., Billard, M., Ashman, L., Gerlier, D., Boucheix, C. and Rubinstein, E. (2003b). Multiple levels of interactions within the tetraspanin web. Biochem. Biophys. Res. Commun. 304, 107-112.
9. Charrin, S., Manie, S., Thiele, C., Billard, M., Gerlier, D., Boucheix, C. and Rubinstein, E. (2003c). A physical and functional link between cholesterol and tetraspanins. Eur. J. Immunol. 33, 2479-2489.
10. Christian, A. E., Haynes, M. P., Phillips, M. C. and Rothblat, G. H. (1997). Use of cyclodextrins for manipulating cellular cholesterol content. J. Lipid Res. 38, 2264-2272.
11. Claas, C., Stipp, C. S. and Hemler, M. E. (2001). Evaluation of prototype transmembrane 4 superfamily protein complexes and their relation to lipid rafts. J. Biol. Chem. 276, 7974-7984.
12. Clark, K. L., Zeng, Z., Langford, A. L., Bowen, S. M. and Todd, S. C. (2001). PGRL is a major CD81-associated protein on lymphocytes and distinguishes a new family of cell surface proteins. J. Immunol. 167, 5115-5121.
13. Clark, K. L., Oelke, A., Johnson, M. E., Eilert, K. D., Simpson, P. C. and Todd, S. C. (2004). CD81 associates with 14-3-3 in a redox-regulated palmitoylation-dependent manner. J. Biol. Chem. 279, 19401-19406.
14. Connelly, M. A. and Williams, D. L. (2004). Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids. Curr. Opin. Lipidol. 15, 287-295.
15. Coppens, I. and Joiner, K. A. (2003). Host but not parasite cholesterol controls Toxoplasma cell entry by modulating organelle discharge. Mol. Biol. Cell 14, 3804-3820.
16. Delaguillaumie, A., Harriague, J., Kohanna, S., Bismuth, G., Rubinstein, E., Seigneuret, M. and Conjeaud, H. (2004). Tetraspanin CD82 controls the association of cholesterol-dependent microdomains with the actin cytoskeleton in T lymphocytes: relevance to co-stimulation. J. Cell Sci. 117, 5269-5282.
17. Feigelson, S. W., Grabovsky, V., Shamri, R., Levy, S. and Alon, R. (2003). The CD81 tetraspanin facilitates instantaneous leukocyte VLA-4 adhesion strengthening to vascular cell adhesion molecule 1 (VCAM-1) under shear flow. J. Biol. Chem. 278, 51203-51212.
18. Friedrichson, T. and Kurzchalia, T. V. (1998). Microdomains of GPI-anchored proteins in living cells revealed by crosslinking. Nature 394, 802-805.
19. Green, J. M., Zhelesnyak, A., Chung, J., Lindberg, F. P., Sarfati, M., Frazier, W. A. and Brown, E. J. (1999). Role of cholesterol in formation and function of a signaling complex involving alphavbeta3, integrin-associated protein (CD47), and heterotrimeric G proteins. J. Cell Biol. 146, 673-682.
20. Gutierrez-Lopez, M. D., Ovalle, S., Yanez-Mo, M., Sanchez-Sanchez, N., Rubinstein, E., Olmo, N., Lizarbe, M. A., Sanchez-Madrid, F. and Cabanas, C. (2003). A functionally relevant conformational epitope on the CD9 tetraspanin depends on the association with activated beta1 integrin. J. Biol. Chem. 278, 208-218.
21. Hemler, M. E. (2003). Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu. Rev. Cell Dev. Biol. 19, 397-422.
22. Hollingdale, M. R., Leland, P. and Schwartz, A. L. (1983). In vitro cultivation of the exoerythrocytic stage of Plasmodium berghei in a hepatoma cell line. Am. J. Trop. Med. Hyg. 32, 682-684.
23. Imai, T. and Yoshie, O. (1993). C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and associate with each other and with CD4 or CD8 in T cells. J. Immunol. 151, 6470-6481.
24. Iwamoto, R., Higashiyama, S., Mitamura, T., Taniguchi, N., Klagsbrun, M. and Mekada, E. (1994). Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J. 13, 2322-2330.
25. Kazarov, A. R., Yang, X., Stipp, C. S., Sehgal, B. and Hemler, M. E. (2002). An extracellular site on tetraspanin CD151 determines alpha 3 and alpha 6 integrin-dependent cellular morphology. J. Cell Biol. 158, 1299-1309.
26. Keller, P. and Simons, K. (1998). Cholesterol is required for surface transport of influenza virus hemagglutinin. J. Cell Biol. 140, 1357-1367.
27. Lammerding, J., Kazarov, A. R., Huang, H., Lee, R. T. and Hemler, M. E. (2003). Tetraspanin CD151 regulates alpha6beta1 integrin adhesion strengthening. Proc. Natl. Acad. Sci. USA 100, 7616-7621.
28. Lauer, S., VanWye, J., Harrison, T., McManus, H., Samuel, B. U., Hiller, N. L., Mohandas, N. and Haldar, K. (2000). Vacuolar uptake of host components, and a role for cholesterol and sphingomyelin in malarial infection. EMBO J. 19, 3556-3564.
29. Le Naour, F., Rubinstein, E., Jasmin, C., Prenant, M. and Boucheix, C. (2000). Severely reduced female fertility in CD9-deficient mice. Science 287, 319-321.
30. Levy, S. and Shoham, T. (2005). The tetraspanin web modulates immune-signalling complexes. Nat. Rev. Immunol. 5, 136-148.
31. Loffler, S., Lottspeich, F., Lanza, F., Azorsa, D. O., ter Meulen, V. and Schneider-Schaulies, J. (1997). CD9, a tetraspan transmembrane protein, renders cells susceptible to canine distemper virus. J. Virol. 71, 42-49.
32. Maecker, H. T. and Levy, S. (1997). Normal lymphocyte development but delayed humoral immune response in CD81-null mice. J. Exp. Med. 185, 1505-1510.
33. Manes, S., del Real, G. and Martinez, A. C. (2003). Pathogens: raft hijackers. Nat. Rev. Immunol. 3, 557-568.
34. Mordue, D. G., Desai, N., Dustin, M. and Sibley, L. D. (1999). Invasion by Toxoplasma gondii establishes a moving junction that selectively excludes host cell plasma membrane proteins on the basis of their membrane anchoring. J. Exp. Med. 190, 1783-1792.
35. Mota, M. M. and Rodriguez, A. (2000). Plasmodium yoelii: efficient in vitro invasion and complete development of sporozoites in mouse hepatic cell lines. Exp. Parasitol. 96, 257-259.
36. Munro, S. (2003). Lipid rafts: elusive or illusive? Cell 115, 377-388.
37. Nishiuchi, R., Sanzen, N., Nada, S., Sumida, Y., Wada, Y., Okada, M., Takagi, J., Hasegawa, H. and Sekiguchi, K. (2005). Potentiation of the ligand-binding activity of integrin (alpha) 3 (beta) 1 via association with tetraspanin CD151. Proc. Natl. Acad. Sci. USA 102, 1939-1944.
38. Odintsova, E., Voortman, J., Gilbert, E. and Berditchevski, F. (2003). Tetrasparin CD82 regulates compartmentalisation and ligand-induced dimerization of EGFR. J. Cell Sci. 116, 4557-4566.
39. Ono, M., Handa, K., Sonnino, S., Withers, D. A., Nagai, H. and Hakomori, S. (2001). GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy. Biochemistry 40, 6414-6421.
40. Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A. J., Houghton, M., Rosa, D., Grandi, G. et al. (1998). Binding of hepatitis C virus to CD81. Science 282, 938-941.
41. Renia, L., Mattei, D., Goma, J., Pied, S., Dubois, P., Miltgen, F., Nussler, A., Matile, H., Menegaux, F., Gentilini, M. et al. (1990). A malaria heat-shock-like determinant expressed on the infected hepatocyte surface is the target of antibody-dependent cell-mediated cytotoxic mechanisms by nonparenchymal liver cells. Eur J. Immunol. 20, 1445-1449.
42. Rubinstein, E., Le Naour, F., Billard, M., Prenant, M. and Boucheix, C. (1994). CD9 antigen is an accessory subunit of the VLA integrin complexes. Eur J. Immunol. 24, 3005-3013.
43. Rubinstein, E., Le Naour, F., Lagaudriere-Gesbert, C., Billard, M., Conjeaud, H. and Boucheix, C. (1996). CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J. Immunol. 26, 2657-2665.
44. Samuel, B. U., Mohandas, N., Harrison, T., McManus, H., Rosse, W., Reid, M. and Haldar, K. (2001). The role of cholesterol and glycosylphosphatidylinositol-anchored proteins of erythrocyte rafts in regulating raft protein content and malarial infection. J. Biol. Chem. 276, 29319-29329.
45. Serru, V., Le Naour, F., Billard, M., Azorsa, D. O., Lanza, F., Boucheix, C. and Rubinstein, E. (1999). Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1. CD151/alpha6beta1) under conditions disrupting tetraspan interactions. Biochem. J. 340, 103-111.
46. Sheets, E. D., Holowka, D. and Baird, B. (1999). Critical role for cholesterol in Lyn-mediated tyrosine phosphorylation of FcepsilonRI and their association with detergent-resistant membranes. J. Cell Biol. 145, 877-887.
47. Shoham, T., Rajapaksa, R., Boucheix, C., Rubinstein, E., Poe, J. C., Tedder, T. F. and Levy, S. (2003). The tetraspanin CD81 regulates the expression of CD19 during B cell development in a postendoplasmic reticulum compartment. J. Immunol. 171, 4062-4072.
48. Silvie, O., Semblat, J. P., Franetich, J. F., Hannoun, L., Eling, W. and Mazier, D. (2002). Effects of irradiation on Plasmodium falciparum sporozoite hepatic development: implications for the design of pre-erythrocytic malaria vaccines. Parasite Immunol. 24, 221-223.
49. Silvie, O., Rubinstein, E., Franetich, J. F., Prenant, M., Belnoue, E., Renia, L., Hannoun, L., Eling, W., Levy, S., Boucheix, C. et al. (2003). Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. Nat. Med. 9, 93-96.
50. Silvie, O., Franetich, J. F., Charrin, S., Mueller, M. S., Siau, A., Bodescot, M., Rubinstein, E., Hannoun, L., Charoenvit, Y., Kocken, C. H. et al. (2004). A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. J. Biol. Chem. 279, 9490-9496.
51. Silvie, O., Greco, C., Franetich, J. F., Dubart-Kupperschmitt, A., Hannoun, L., Van Gemert, G. J., Sauerwein, R. W., Levy, S., Boucheix, C., Rubinstein, E. et al. (2006). Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species. Cell Microbiol. (in press).
52. Simons, K. and Ikonen, E. (1997). Functional rafts in cell membranes. Nature 387, 569-572.
53. Simons, K. and Ehehalt, R. (2002). Cholesterol, lipid rafts, and disease. J. Clin. Invest. 110, 597-603.
54. Sterk, L. M., Geuijen, C. A., van den Berg, J. G., Claessen, N., Weening, J. J. and Sonnenberg, A. (2002). Association of the tetraspanin CD151 with the laminin-binding integrins alpha3beta1, alpha6beta1, alpha6beta4 and alpha7beta1 in cells in culture and in vivo. J. Cell Sci. 115, 1161-1173.
55. Stipp, C. S., Kolesnikova, T. V. and Hemler, M. E. (2001a). EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily. J. Biol. Chem. 276, 40545-40554.
56. Stipp, C. S., Orlicky, D. and Hemler, M. E. (2001b). FPRP, a major, highly stoichiometric, highly specific CD81- and CD9-associated protein. J. Biol. Chem. 276, 4853-4862.
57. Varma, R. and Mayor, S. (1998). GPI-anchored proteins are organized in submicron domains at the cell surface. Nature 394, 798-801.
58. Voisset, C., Callens, N., Blanchard, E., Op De Beeck, A., Dubuisson, J. and Vu-Dac, N. (2005). High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J. Biol. Chem. 280, 7793-7799.
59. von Lindern, J. J., Rojo, D., Grovit-Ferbas, K., Yeramian, C., Deng, C., Herbein, G., Ferguson, M. R., Pappas, T. C., Decker, J. M., Singh, A. et al. (2003). Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages. J. Virol. 77, 3624-3633.
60. Weil, D., Garcon, L., Harper, M., Dumenil, D., Dautry, F. and Kress, M. (2002). Targeting the kinesin Eg5 to monitor siRNA transfection in mammalian cells. Biotechniques 33, 1244-1248.
61. Willett, B. J., Flynn, J. N. and Hosie, M. J. (1997). FIV infection of the domestic cat: an animal model for AIDS. Immunol. Today 18, 182-189.
62. Wurst, W. and Joyner, A. L. (1993). Production of targeted embryonic stem cell clones. In Gene Targeting: A Practical Approach (ed. A. L. Joyner), pp. 33-62. Oxford: Oxford University Press.
63. Yancey, P. G., Rodrigueza, W. V., Kilsdonk, E. P., Stoudt, G. W., Johnson, W. J., Phillips, M. C. and Rothblat, G. H. (1996). Cellular cholesterol efflux mediated by cyclodextrins. Demonstration of kinetic pools and mechanism of efflux. J Biol. Chem. 271, 16026-16034.
64. Yang, X., Claas, C., Kraeft, S. K., Chen, L. B., Wang, Z., Kreidberg, J. A. and Hemler, M. E. (2002). Palmitoylation of tetraspain proteins: modulation of CD151 lateral interactions, subcellular distribution, and integrin-dependent cell morphology. Mol. Biol. Cell 13, 767-781.
65. Yauch, R. L., Berditchevski, F., Harler, M. B., Reichner, J. and Hemler, M. E. (1998). Highly stoichiometric, stable, and specific association of integrin alpha3beta1 with CD151 provides a major link to phosphatidylinositol 4-kinase, and may regulate cell migration. Mol. Biol. Cell 9, 2751-2765.
66. Zhang, J., Randall, G., Higginbottom, A., Monk, P., Rice, C. M. and McKeating, J. A. (2004). CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J. Virol. 78, 1448-1455.